English

MERIDIAN BIOSCIENCE INC

EDGAR

VIVO Quarterly report (10-Q) · filed 2023-02-09

125 filing records in this dataset, filed from 1995-08-02 to 2023-02-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

56.9 million USD

2023 Q1 · USD

Exact inputs and evidence

Revenue: 56902000 USD Source

Operating margin

-49.41%

2023 Q1 · %

Exact inputs and evidence

Operating Income: -28115000 USD Source
Revenue: 56902000 USD Source

Operating cash flow

-2.35 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -2349000 USD Source

Free cash flow

-5 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -2349000 USD Source
Capital Expenditure: 2654000 USD Source

Cash and cash equivalents: 74.1 million USD 2022-12-31 Source
Exact value

74098000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 43.8 million shares 2022-12-31 Source
Exact value

43755188 shares

Reported share-count change

0.55% · 241 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

43514258 shares · 2021-12-31· Source
43755188 shares · 2022-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

302 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Revenue: 111231000 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 67771000 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 333018000 USD · 2021-10-01 – 2022-09-30 Source
Revenue: 267343000 USD · 2021-10-01 – 2022-06-30 Source
Revenue: 56902000 USD · 2022-10-01 – 2022-12-31 Source

Net income

-2.7 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Net income: 28752000 USD · 2022-01-01 – 2022-03-31 Source
Net income: -7338000 USD · 2022-04-01 – 2022-06-30 Source
Net income: 42459000 USD · 2021-10-01 – 2022-09-30 Source
Net income: 36754000 USD · 2021-10-01 – 2022-06-30 Source
Net income: -29821000 USD · 2022-10-01 – 2022-12-31 Source

Operating cash flow

44.5 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Operating cash flow: 65972000 USD · 2021-10-01 – 2022-03-31 Source
Operating cash flow: 35555000 USD · 2021-10-01 – 2021-12-31 Source
Operating cash flow: 80374000 USD · 2021-10-01 – 2022-06-30 Source
Operating cash flow: 65972000 USD · 2021-10-01 – 2022-03-31 Source
Operating cash flow: 82361000 USD · 2021-10-01 – 2022-09-30 Source
Operating cash flow: 80374000 USD · 2021-10-01 – 2022-06-30 Source
Operating cash flow: -2349000 USD · 2022-10-01 – 2022-12-31 Source

Capital expenditure

9.56 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Capital expenditure: 3179000 USD · 2021-10-01 – 2022-03-31 Source
Capital expenditure: 1708000 USD · 2021-10-01 – 2021-12-31 Source
Capital expenditure: 5138000 USD · 2021-10-01 – 2022-06-30 Source
Capital expenditure: 3179000 USD · 2021-10-01 – 2022-03-31 Source
Capital expenditure: 8615000 USD · 2021-10-01 – 2022-09-30 Source
Capital expenditure: 5138000 USD · 2021-10-01 – 2022-06-30 Source
Capital expenditure: 2654000 USD · 2022-10-01 – 2022-12-31 Source

Free cash flow

34.9 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Operating cash flow: 65972000 USD · 2021-10-01 – 2022-03-31 Source
Operating cash flow: 35555000 USD · 2021-10-01 – 2021-12-31 Source
Operating cash flow: 80374000 USD · 2021-10-01 – 2022-06-30 Source
Operating cash flow: 65972000 USD · 2021-10-01 – 2022-03-31 Source
Operating cash flow: 82361000 USD · 2021-10-01 – 2022-09-30 Source
Operating cash flow: 80374000 USD · 2021-10-01 – 2022-06-30 Source
Operating cash flow: -2349000 USD · 2022-10-01 – 2022-12-31 Source
Capital expenditure: 3179000 USD · 2021-10-01 – 2022-03-31 Source
Capital expenditure: 1708000 USD · 2021-10-01 – 2021-12-31 Source
Capital expenditure: 5138000 USD · 2021-10-01 – 2022-06-30 Source
Capital expenditure: 3179000 USD · 2021-10-01 – 2022-03-31 Source
Capital expenditure: 8615000 USD · 2021-10-01 – 2022-09-30 Source
Capital expenditure: 5138000 USD · 2021-10-01 – 2022-06-30 Source
Capital expenditure: 2654000 USD · 2022-10-01 – 2022-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-02-09.

Financial data available through: 2022-09-30.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-09-30
Operating income: 11 of 11 periods available· newest 2022-09-30
Net income: 11 of 11 periods available· newest 2022-09-30
Operating cash flow: 11 of 11 periods available· newest 2022-09-30
Capital expenditure: 11 of 11 periods available· newest 2022-09-30
Total assets: 11 of 11 periods available· newest 2022-09-30
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2022-09-30
Current liabilities: 11 of 11 periods available· newest 2022-09-30
Cash and cash equivalents: 11 of 11 periods available· newest 2022-09-30
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2022-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+4.8%

Prior period

USD 317.9 million

2020-10-01 – 2021-09-30
Current period

USD 333.02 million

2021-10-01 – 2022-09-30

Exact inputs and evidence

333018000 − 317896000 = 15122000 USD

317896000 USD · 2020-10-01 – 2021-09-30
Inspect prior input Prior source
333018000 USD · 2021-10-01 – 2022-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Year-over-year change in Revenue: 15122000 USD Concept: fundies:Revenue Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 333018000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1779444 Filing: 000119312522290521 Input fundies:Revenue: 317896000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1810070 Filing: 000119312522290521
The citation records this snapshot. The page link may show a newer release later.
Net income
-40.5%

Prior period

USD 71.41 million

2020-10-01 – 2021-09-30
Current period

USD 42.46 million

2021-10-01 – 2022-09-30

Exact inputs and evidence

42459000 − 71407000 = -28948000 USD

71407000 USD · 2020-10-01 – 2021-09-30
Inspect prior input Prior source
42459000 USD · 2021-10-01 – 2022-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Year-over-year change in Net income: -28948000 USD Concept: fundies:NetIncome Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 42459000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1092310 Filing: 000119312522290521 Input fundies:NetIncome: 71407000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1062919 Filing: 000119312522290521
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+23.2%

Prior period

USD 66.87 million

2020-10-01 – 2021-09-30
Current period

USD 82.36 million

2021-10-01 – 2022-09-30

Exact inputs and evidence

82361000 − 66865000 = 15496000 USD

66865000 USD · 2020-10-01 – 2021-09-30
Inspect prior input Prior source
82361000 USD · 2021-10-01 – 2022-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Year-over-year change in Operating cash flow: 15496000 USD Concept: fundies:OperatingCashFlow Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 82361000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#834172 Filing: 000119312522290521 Input fundies:OperatingCashFlow: 66865000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#834678 Filing: 000119312522290521
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-53%

Prior period

USD 18.31 million

2020-10-01 – 2021-09-30
Current period

USD 8.62 million

2021-10-01 – 2022-09-30

Exact inputs and evidence

8615000 − 18312000 = -9697000 USD

18312000 USD · 2020-10-01 – 2021-09-30
Inspect prior input Prior source
8615000 USD · 2021-10-01 – 2022-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Year-over-year change in Capital expenditure: -9697000 USD Concept: fundies:CapitalExpenditure Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8615000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1791117 Filing: 000119312522290521 Input fundies:CapitalExpenditure: 18312000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1821692 Filing: 000119312522290521
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2021-10-01 – 2022-09-30

Revenue USD 333.02 million 100% of revenue
Cost of revenue USD 144.66 million 43% of revenue
Operating expenses USD 133.97 million 40% of revenue
Operating income USD 54.39 million 16% of revenue
Tax, interest and other Derived USD 11.93 million 3.6% of revenue
Net income USD 42.46 million 13% of revenue

Cash

Operating cash flow USD 82.36 million 25% of revenue
Capital expenditure USD 8.62 million 2.6% of revenue
Free cash flow Derived USD 73.75 million 22% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 20%10%70%
2014 18%9.3%72%
2015 18%11%71%
2016 16%9.8%74%
2017 11%81%
2018 11%85%
2019 12%84%
2020 18%76%
2021 22%71%
2022 13%84%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2012-10-01 – 2013-09-30	188686000	131372000 Derived	57314000	19282000 Derived	38032000	41202000 Derived	Source 2012-10-01 – 2013-09-30: 188686000 USD Inspect Revenue Open source 2012-10-01 – 2013-09-30: 57314000 USD Inspect Operating Income Open source 2012-10-01 – 2013-09-30: 38032000 USD Inspect Net Income Open source 2012-10-01 – 2013-09-30: 44436000 USD Inspect Operating Cash Flow Open source 2012-10-01 – 2013-09-30: 3234000 USD Inspect Capital Expenditure Open source
2014 2013-10-01 – 2014-09-30	188832000	136440000 Derived	52392000	17649000 Derived	34743000	32956000 Derived	Source 2013-10-01 – 2014-09-30: 188832000 USD Inspect Revenue Open source 2013-10-01 – 2014-09-30: 52392000 USD Inspect Operating Income Open source 2013-10-01 – 2014-09-30: 34743000 USD Inspect Net Income Open source 2013-10-01 – 2014-09-30: 38262000 USD Inspect Operating Cash Flow Open source 2013-10-01 – 2014-09-30: 5306000 USD Inspect Capital Expenditure Open source
2015 2014-10-01 – 2015-09-30	194830000	138770000 Derived	56060000	20520000 Derived	35540000	38196000 Derived	Source 2014-10-01 – 2015-09-30: 194830000 USD Inspect Revenue Open source 2014-10-01 – 2015-09-30: 56060000 USD Inspect Operating Income Open source 2014-10-01 – 2015-09-30: 35540000 USD Inspect Net Income Open source 2014-10-01 – 2015-09-30: 42809000 USD Inspect Operating Cash Flow Open source 2014-10-01 – 2015-09-30: 4613000 USD Inspect Capital Expenditure Open source
2016 2015-10-01 – 2016-09-30	196082000	144704000 Derived	51378000	19149000 Derived	32229000	33219000 Derived	Source 2015-10-01 – 2016-09-30: 196082000 USD Inspect Revenue Open source 2015-10-01 – 2016-09-30: 51378000 USD Inspect Operating Income Open source 2015-10-01 – 2016-09-30: 32229000 USD Inspect Net Income Open source 2015-10-01 – 2016-09-30: 37223000 USD Inspect Operating Cash Flow Open source 2015-10-01 – 2016-09-30: 4004000 USD Inspect Capital Expenditure Open source
2017 2016-10-01 – 2017-09-30	200771000	163389000 Derived	37382000	15825000 Derived	21557000	36888000 Derived	Source 2016-10-01 – 2017-09-30: 200771000 USD Inspect Revenue Open source 2016-10-01 – 2017-09-30: 37382000 USD Inspect Operating Income Open source 2016-10-01 – 2017-09-30: 21557000 USD Inspect Net Income Open source 2016-10-01 – 2017-09-30: 41355000 USD Inspect Operating Cash Flow Open source 2016-10-01 – 2017-09-30: 4467000 USD Inspect Capital Expenditure Open source
2018 2017-10-01 – 2018-09-30	213571000	181987000 Derived	31584000	7735000 Derived	23849000	30586000 Derived	Source 2017-10-01 – 2018-09-30: 213571000 USD Inspect Revenue Open source 2017-10-01 – 2018-09-30: 31584000 USD Inspect Operating Income Open source 2017-10-01 – 2018-09-30: 23849000 USD Inspect Net Income Open source 2017-10-01 – 2018-09-30: 34787000 USD Inspect Operating Cash Flow Open source 2017-10-01 – 2018-09-30: 4201000 USD Inspect Capital Expenditure Open source
2019 2018-10-01 – 2019-09-30	201014000	168315000 Derived	32699000	8317000 Derived	24382000	32378000 Derived	Source 2018-10-01 – 2019-09-30: 201014000 USD Inspect Revenue Open source 2018-10-01 – 2019-09-30: 32699000 USD Inspect Operating Income Open source 2018-10-01 – 2019-09-30: 24382000 USD Inspect Net Income Open source 2018-10-01 – 2019-09-30: 36175000 USD Inspect Operating Cash Flow Open source 2018-10-01 – 2019-09-30: 3797000 USD Inspect Capital Expenditure Open source
2020 2019-10-01 – 2020-09-30	253667000	192343000 Derived	61324000	15138000 Derived	46186000	44677000 Derived	Source 2019-10-01 – 2020-09-30: 253667000 USD Inspect Revenue Open source 2019-10-01 – 2020-09-30: 61324000 USD Inspect Operating Income Open source 2019-10-01 – 2020-09-30: 46186000 USD Inspect Net Income Open source 2019-10-01 – 2020-09-30: 47976000 USD Inspect Operating Cash Flow Open source 2019-10-01 – 2020-09-30: 3299000 USD Inspect Capital Expenditure Open source
2021 2020-10-01 – 2021-09-30	317896000	224862000 Derived	93034000	21627000 Derived	71407000	48553000 Derived	Source 2020-10-01 – 2021-09-30: 317896000 USD Inspect Revenue Open source 2020-10-01 – 2021-09-30: 93034000 USD Inspect Operating Income Open source 2020-10-01 – 2021-09-30: 71407000 USD Inspect Net Income Open source 2020-10-01 – 2021-09-30: 66865000 USD Inspect Operating Cash Flow Open source 2020-10-01 – 2021-09-30: 18312000 USD Inspect Capital Expenditure Open source
2022 2021-10-01 – 2022-09-30	333018000	278627000 Derived	54391000	11932000 Derived	42459000	73746000 Derived	Source 2021-10-01 – 2022-09-30: 333018000 USD Inspect Revenue Open source 2021-10-01 – 2022-09-30: 54391000 USD Inspect Operating Income Open source 2021-10-01 – 2022-09-30: 42459000 USD Inspect Net Income Open source 2021-10-01 – 2022-09-30: 82361000 USD Inspect Operating Cash Flow Open source 2021-10-01 – 2022-09-30: 8615000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 333M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-09-30	Revenue	188686000	Revenue: 188686000 Open source
20142014-09-30	Revenue	188832000	Revenue: 188832000 Open source
20152015-09-30	Revenue	194830000	Revenue: 194830000 Open source
20162016-09-30	Revenue	196082000	Revenue: 196082000 Open source
20172017-09-30	Revenue	200771000	Revenue: 200771000 Open source
20182018-09-30	Revenue	213571000	Revenue: 213571000 Open source
20192019-09-30	Revenue	201014000	Revenue: 201014000 Open source
20202020-09-30	Revenue	253667000	Revenue: 253667000 Open source
20212021-09-30	Revenue	317896000	Revenue: 317896000 Open source
20222022-09-30	Revenue	333018000	Revenue: 333018000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

4.8% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-09-30	Year over year	9.2%	Revenue: 188686000 Open source Revenue: 172712000 Open source
20142014-09-30	Year over year	0.1%	Revenue: 188832000 Open source Revenue: 188686000 Open source
20152015-09-30	Year over year	3.2%	Revenue: 194830000 Open source Revenue: 188832000 Open source
20162016-09-30	Year over year	0.6%	Revenue: 196082000 Open source Revenue: 194830000 Open source
20172017-09-30	Year over year	2.4%	Revenue: 200771000 Open source Revenue: 196082000 Open source
20182018-09-30	Year over year	6.4%	Revenue: 213571000 Open source Revenue: 200771000 Open source
20192019-09-30	Year over year	-5.9%	Revenue: 201014000 Open source Revenue: 213571000 Open source
20202020-09-30	Year over year	26.2%	Revenue: 253667000 Open source Revenue: 201014000 Open source
20212021-09-30	Year over year	25.3%	Revenue: 317896000 Open source Revenue: 253667000 Open source
20222022-09-30	Year over year	4.8%	Revenue: 333018000 Open source Revenue: 317896000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 16.3% 2022

Net margin 12.7% 2022

Free cash flow margin 22.1% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-09-30	Operating margin	30.4%	Operating Income: 57314000 Open source Revenue: 188686000 Open source
20142014-09-30	Operating margin	27.7%	Operating Income: 52392000 Open source Revenue: 188832000 Open source
20152015-09-30	Operating margin	28.8%	Operating Income: 56060000 Open source Revenue: 194830000 Open source
20162016-09-30	Operating margin	26.2%	Operating Income: 51378000 Open source Revenue: 196082000 Open source
20172017-09-30	Operating margin	18.6%	Operating Income: 37382000 Open source Revenue: 200771000 Open source
20182018-09-30	Operating margin	14.8%	Operating Income: 31584000 Open source Revenue: 213571000 Open source
20192019-09-30	Operating margin	16.3%	Operating Income: 32699000 Open source Revenue: 201014000 Open source
20202020-09-30	Operating margin	24.2%	Operating Income: 61324000 Open source Revenue: 253667000 Open source
20212021-09-30	Operating margin	29.3%	Operating Income: 93034000 Open source Revenue: 317896000 Open source
20222022-09-30	Operating margin	16.3%	Operating Income: 54391000 Open source Revenue: 333018000 Open source
20132013-09-30	Net margin	20.2%	Net Income: 38032000 Open source Revenue: 188686000 Open source
20142014-09-30	Net margin	18.4%	Net Income: 34743000 Open source Revenue: 188832000 Open source
20152015-09-30	Net margin	18.2%	Net Income: 35540000 Open source Revenue: 194830000 Open source
20162016-09-30	Net margin	16.4%	Net Income: 32229000 Open source Revenue: 196082000 Open source
20172017-09-30	Net margin	10.7%	Net Income: 21557000 Open source Revenue: 200771000 Open source
20182018-09-30	Net margin	11.2%	Net Income: 23849000 Open source Revenue: 213571000 Open source
20192019-09-30	Net margin	12.1%	Net Income: 24382000 Open source Revenue: 201014000 Open source
20202020-09-30	Net margin	18.2%	Net Income: 46186000 Open source Revenue: 253667000 Open source
20212021-09-30	Net margin	22.5%	Net Income: 71407000 Open source Revenue: 317896000 Open source
20222022-09-30	Net margin	12.7%	Net Income: 42459000 Open source Revenue: 333018000 Open source
20132013-09-30	Free cash flow margin	21.8%	Revenue: 188686000 Open source Operating Cash Flow: 44436000 Open source Capital Expenditure: 3234000 Open source
20142014-09-30	Free cash flow margin	17.5%	Revenue: 188832000 Open source Operating Cash Flow: 38262000 Open source Capital Expenditure: 5306000 Open source
20152015-09-30	Free cash flow margin	19.6%	Revenue: 194830000 Open source Operating Cash Flow: 42809000 Open source Capital Expenditure: 4613000 Open source
20162016-09-30	Free cash flow margin	16.9%	Revenue: 196082000 Open source Operating Cash Flow: 37223000 Open source Capital Expenditure: 4004000 Open source
20172017-09-30	Free cash flow margin	18.4%	Revenue: 200771000 Open source Operating Cash Flow: 41355000 Open source Capital Expenditure: 4467000 Open source
20182018-09-30	Free cash flow margin	14.3%	Revenue: 213571000 Open source Operating Cash Flow: 34787000 Open source Capital Expenditure: 4201000 Open source
20192019-09-30	Free cash flow margin	16.1%	Revenue: 201014000 Open source Operating Cash Flow: 36175000 Open source Capital Expenditure: 3797000 Open source
20202020-09-30	Free cash flow margin	17.6%	Revenue: 253667000 Open source Operating Cash Flow: 47976000 Open source Capital Expenditure: 3299000 Open source
20212021-09-30	Free cash flow margin	15.3%	Revenue: 317896000 Open source Operating Cash Flow: 66865000 Open source Capital Expenditure: 18312000 Open source
20222022-09-30	Free cash flow margin	22.1%	Revenue: 333018000 Open source Operating Cash Flow: 82361000 Open source Capital Expenditure: 8615000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 82.4M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-09-30	Operating cash flow	44436000	Operating Cash Flow: 44436000 Open source
20142014-09-30	Operating cash flow	38262000	Operating Cash Flow: 38262000 Open source
20152015-09-30	Operating cash flow	42809000	Operating Cash Flow: 42809000 Open source
20162016-09-30	Operating cash flow	37223000	Operating Cash Flow: 37223000 Open source
20172017-09-30	Operating cash flow	41355000	Operating Cash Flow: 41355000 Open source
20182018-09-30	Operating cash flow	34787000	Operating Cash Flow: 34787000 Open source
20192019-09-30	Operating cash flow	36175000	Operating Cash Flow: 36175000 Open source
20202020-09-30	Operating cash flow	47976000	Operating Cash Flow: 47976000 Open source
20212021-09-30	Operating cash flow	66865000	Operating Cash Flow: 66865000 Open source
20222022-09-30	Operating cash flow	82361000	Operating Cash Flow: 82361000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 73.7M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-09-30	Free cash flow	41202000	Operating Cash Flow: 44436000 Open source Capital Expenditure: 3234000 Open source
20142014-09-30	Free cash flow	32956000	Operating Cash Flow: 38262000 Open source Capital Expenditure: 5306000 Open source
20152015-09-30	Free cash flow	38196000	Operating Cash Flow: 42809000 Open source Capital Expenditure: 4613000 Open source
20162016-09-30	Free cash flow	33219000	Operating Cash Flow: 37223000 Open source Capital Expenditure: 4004000 Open source
20172017-09-30	Free cash flow	36888000	Operating Cash Flow: 41355000 Open source Capital Expenditure: 4467000 Open source
20182018-09-30	Free cash flow	30586000	Operating Cash Flow: 34787000 Open source Capital Expenditure: 4201000 Open source
20192019-09-30	Free cash flow	32378000	Operating Cash Flow: 36175000 Open source Capital Expenditure: 3797000 Open source
20202020-09-30	Free cash flow	44677000	Operating Cash Flow: 47976000 Open source Capital Expenditure: 3299000 Open source
20212021-09-30	Free cash flow	48553000	Operating Cash Flow: 66865000 Open source Capital Expenditure: 18312000 Open source
20222022-09-30	Free cash flow	73746000	Operating Cash Flow: 82361000 Open source Capital Expenditure: 8615000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2013-09-30	Liabilities / assets	Not reported	Total Assets: 176748000 Open source
2014-09-30	Liabilities / assets	Not reported	Total Assets: 176929000 Open source
2015-09-30	Liabilities / assets	Not reported	Total Assets: 183282000 Open source
2016-09-30	Liabilities / assets	Not reported	Total Assets: 252028000 Open source
2017-09-30	Liabilities / assets	Not reported	Total Assets: 249777000 Open source
2018-09-30	Liabilities / assets	Not reported	Total Assets: 251377000 Open source
2019-09-30	Liabilities / assets	Not reported	Total Assets: 325478000 Open source
2020-09-30	Liabilities / assets	Not reported	Total Assets: 405261000 Open source
2021-09-30	Liabilities / assets	Not reported	Total Assets: 449722000 Open source
2022-09-30	Liabilities / assets	Not reported	Total Assets: 463097000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.63× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-09-30	Current assets / current liabilities	5.82×	Current Assets: 114088000 Open source Current Liabilities: 19617000 Open source
20142014-09-30	Current assets / current liabilities	8.21×	Current Assets: 112748000 Open source Current Liabilities: 13735000 Open source
20152015-09-30	Current assets / current liabilities	7.83×	Current Assets: 119422000 Open source Current Liabilities: 15251000 Open source
20162016-09-30	Current assets / current liabilities	5.62×	Current Assets: 126791000 Open source Current Liabilities: 22571000 Open source
20172017-09-30	Current assets / current liabilities	5.85×	Current Assets: 133875000 Open source Current Liabilities: 22887000 Open source
20182018-09-30	Current assets / current liabilities	5.75×	Current Assets: 139053000 Open source Current Liabilities: 24173000 Open source
20192019-09-30	Current assets / current liabilities	6.92×	Current Assets: 144761000 Open source Current Liabilities: 20914000 Open source
20202020-09-30	Current assets / current liabilities	3.09×	Current Assets: 162190000 Open source Current Liabilities: 52524000 Open source
20212021-09-30	Current assets / current liabilities	4.09×	Current Assets: 192807000 Open source Current Liabilities: 47157000 Open source
20222022-09-30	Current assets / current liabilities	3.63×	Current Assets: 210597000 Open source Current Liabilities: 57951000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2012-10-01 – 2013-09-30	USD 38.03 million Exact value Exact value: 38032000 USD 2012-10-01 – 2013-09-30: 38032000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2013-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 38032000 USD Concept: fundies:NetIncome Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2013-09-30&surface=latest&period_type=duration&start=2012-10-01&unit=USD&dimensions= Input fundies:NetIncome: 38032000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312515390041/vivo-20150930.xml#79718 Filing: 000119312515390041 The citation records this snapshot. The page link may show a newer release later.	USD 44.44 million Exact value Exact value: 44436000 USD 2012-10-01 – 2013-09-30: 44436000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2013-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 44436000 USD Concept: fundies:OperatingCashFlow Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2013-09-30&surface=latest&period_type=duration&start=2012-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 44436000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312515390041/vivo-20150930.xml#73430 Filing: 000119312515390041 The citation records this snapshot. The page link may show a newer release later.	USD 3.23 million Exact value Exact value: 3234000 USD 2012-10-01 – 2013-09-30: 3234000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2013-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 3234000 USD Concept: fundies:CapitalExpenditure Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2013-09-30&surface=latest&period_type=duration&start=2012-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3234000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312515390041/vivo-20150930.xml#79202 Filing: 000119312515390041 The citation records this snapshot. The page link may show a newer release later.	USD 41.2 million Calculation and evidence 44436000 − 3234000 USD Exact free cash flow: 41202000 USD 2012-10-01 – 2013-09-30: 44436000 USD · Inspect Operating Cash Flow · Source 2012-10-01 – 2013-09-30: 3234000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2013-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 41202000 USD Concept: free-cash-flow Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 44436000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312515390041/vivo-20150930.xml#73430 Filing: 000119312515390041 Input fundies:CapitalExpenditure: 3234000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312515390041/vivo-20150930.xml#79202 Filing: 000119312515390041 The citation records this snapshot. The page link may show a newer release later.
2014 2013-10-01 – 2014-09-30	USD 34.74 million Exact value Exact value: 34743000 USD 2013-10-01 – 2014-09-30: 34743000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2014-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 34743000 USD Concept: fundies:NetIncome Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2014-09-30&surface=latest&period_type=duration&start=2013-10-01&unit=USD&dimensions= Input fundies:NetIncome: 34743000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312516779250/vivo-20160930.xml#108375 Filing: 000119312516779250 The citation records this snapshot. The page link may show a newer release later.	USD 38.26 million Exact value Exact value: 38262000 USD 2013-10-01 – 2014-09-30: 38262000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2014-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 38262000 USD Concept: fundies:OperatingCashFlow Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2014-09-30&surface=latest&period_type=duration&start=2013-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 38262000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312516779250/vivo-20160930.xml#114505 Filing: 000119312516779250 The citation records this snapshot. The page link may show a newer release later.	USD 5.31 million Exact value Exact value: 5306000 USD 2013-10-01 – 2014-09-30: 5306000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2014-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 5306000 USD Concept: fundies:CapitalExpenditure Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2014-09-30&surface=latest&period_type=duration&start=2013-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5306000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312516779250/vivo-20160930.xml#115337 Filing: 000119312516779250 The citation records this snapshot. The page link may show a newer release later.	USD 32.96 million Calculation and evidence 38262000 − 5306000 USD Exact free cash flow: 32956000 USD 2013-10-01 – 2014-09-30: 38262000 USD · Inspect Operating Cash Flow · Source 2013-10-01 – 2014-09-30: 5306000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2014-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 32956000 USD Concept: free-cash-flow Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 38262000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312516779250/vivo-20160930.xml#114505 Filing: 000119312516779250 Input fundies:CapitalExpenditure: 5306000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312516779250/vivo-20160930.xml#115337 Filing: 000119312516779250 The citation records this snapshot. The page link may show a newer release later.
2015 2014-10-01 – 2015-09-30	USD 35.54 million Exact value Exact value: 35540000 USD 2014-10-01 – 2015-09-30: 35540000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2015-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 35540000 USD Concept: fundies:NetIncome Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:NetIncome: 35540000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312517354808/vivo-20170930.xml#117070 Filing: 000119312517354808 The citation records this snapshot. The page link may show a newer release later.	USD 42.81 million Exact value Exact value: 42809000 USD 2014-10-01 – 2015-09-30: 42809000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2015-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 42809000 USD Concept: fundies:OperatingCashFlow Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 42809000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312517354808/vivo-20170930.xml#116235 Filing: 000119312517354808 The citation records this snapshot. The page link may show a newer release later.	USD 4.61 million Exact value Exact value: 4613000 USD 2014-10-01 – 2015-09-30: 4613000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2015-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 4613000 USD Concept: fundies:CapitalExpenditure Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4613000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312517354808/vivo-20170930.xml#119837 Filing: 000119312517354808 The citation records this snapshot. The page link may show a newer release later.	USD 38.2 million Calculation and evidence 42809000 − 4613000 USD Exact free cash flow: 38196000 USD 2014-10-01 – 2015-09-30: 42809000 USD · Inspect Operating Cash Flow · Source 2014-10-01 – 2015-09-30: 4613000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2015-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 38196000 USD Concept: free-cash-flow Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 42809000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312517354808/vivo-20170930.xml#116235 Filing: 000119312517354808 Input fundies:CapitalExpenditure: 4613000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312517354808/vivo-20170930.xml#119837 Filing: 000119312517354808 The citation records this snapshot. The page link may show a newer release later.
2016 2015-10-01 – 2016-09-30	USD 32.23 million Exact value Exact value: 32229000 USD 2015-10-01 – 2016-09-30: 32229000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2016-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 32229000 USD Concept: fundies:NetIncome Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:NetIncome: 32229000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312518337257/vivo-20180930.xml#968547 Filing: 000119312518337257 The citation records this snapshot. The page link may show a newer release later.	USD 37.22 million Exact value Exact value: 37223000 USD 2015-10-01 – 2016-09-30: 37223000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2016-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 37223000 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 37223000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312518337257/vivo-20180930.xml#968279 Filing: 000119312518337257 The citation records this snapshot. The page link may show a newer release later.	USD 4 million Exact value Exact value: 4004000 USD 2015-10-01 – 2016-09-30: 4004000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2016-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 4004000 USD Concept: fundies:CapitalExpenditure Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4004000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312518337257/vivo-20180930.xml#972612 Filing: 000119312518337257 The citation records this snapshot. The page link may show a newer release later.	USD 33.22 million Calculation and evidence 37223000 − 4004000 USD Exact free cash flow: 33219000 USD 2015-10-01 – 2016-09-30: 37223000 USD · Inspect Operating Cash Flow · Source 2015-10-01 – 2016-09-30: 4004000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2016-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 33219000 USD Concept: free-cash-flow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 37223000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312518337257/vivo-20180930.xml#968279 Filing: 000119312518337257 Input fundies:CapitalExpenditure: 4004000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312518337257/vivo-20180930.xml#972612 Filing: 000119312518337257 The citation records this snapshot. The page link may show a newer release later.
2017 2016-10-01 – 2017-09-30	USD 21.56 million Exact value Exact value: 21557000 USD 2016-10-01 – 2017-09-30: 21557000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2017-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 21557000 USD Concept: fundies:NetIncome Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:NetIncome: 21557000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312519300565/d785397d10k.htm#1607513 Filing: 000119312519300565 The citation records this snapshot. The page link may show a newer release later.	USD 41.36 million Exact value Exact value: 41355000 USD 2016-10-01 – 2017-09-30: 41355000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2017-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 41355000 USD Concept: fundies:OperatingCashFlow Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 41355000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312519300565/d785397d10k.htm#1281564 Filing: 000119312519300565 The citation records this snapshot. The page link may show a newer release later.	USD 4.47 million Exact value Exact value: 4467000 USD 2016-10-01 – 2017-09-30: 4467000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2017-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 4467000 USD Concept: fundies:CapitalExpenditure Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2017-09-30&surface=latest&period_type=duration&start=2016-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4467000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312519300565/d785397d10k.htm#3226075 Filing: 000119312519300565 The citation records this snapshot. The page link may show a newer release later.	USD 36.89 million Calculation and evidence 41355000 − 4467000 USD Exact free cash flow: 36888000 USD 2016-10-01 – 2017-09-30: 41355000 USD · Inspect Operating Cash Flow · Source 2016-10-01 – 2017-09-30: 4467000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2017-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 36888000 USD Concept: free-cash-flow Period: 2016-10-01 to 2017-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 41355000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312519300565/d785397d10k.htm#1281564 Filing: 000119312519300565 Input fundies:CapitalExpenditure: 4467000 USD (2016-10-01 to 2017-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312519300565/d785397d10k.htm#3226075 Filing: 000119312519300565 The citation records this snapshot. The page link may show a newer release later.
2018 2017-10-01 – 2018-09-30	USD 23.85 million Exact value Exact value: 23849000 USD 2017-10-01 – 2018-09-30: 23849000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2018-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 23849000 USD Concept: fundies:NetIncome Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:NetIncome: 23849000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312520300813/d24550d10k.htm#1281193 Filing: 000119312520300813 The citation records this snapshot. The page link may show a newer release later.	USD 34.79 million Exact value Exact value: 34787000 USD 2017-10-01 – 2018-09-30: 34787000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2018-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 34787000 USD Concept: fundies:OperatingCashFlow Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 34787000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312520300813/d24550d10k.htm#1047830 Filing: 000119312520300813 The citation records this snapshot. The page link may show a newer release later.	USD 4.2 million Exact value Exact value: 4201000 USD 2017-10-01 – 2018-09-30: 4201000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2018-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 4201000 USD Concept: fundies:CapitalExpenditure Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2018-09-30&surface=latest&period_type=duration&start=2017-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4201000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312520300813/d24550d10k.htm#2520429 Filing: 000119312520300813 The citation records this snapshot. The page link may show a newer release later.	USD 30.59 million Calculation and evidence 34787000 − 4201000 USD Exact free cash flow: 30586000 USD 2017-10-01 – 2018-09-30: 34787000 USD · Inspect Operating Cash Flow · Source 2017-10-01 – 2018-09-30: 4201000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2018-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 30586000 USD Concept: free-cash-flow Period: 2017-10-01 to 2018-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 34787000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312520300813/d24550d10k.htm#1047830 Filing: 000119312520300813 Input fundies:CapitalExpenditure: 4201000 USD (2017-10-01 to 2018-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312520300813/d24550d10k.htm#2520429 Filing: 000119312520300813 The citation records this snapshot. The page link may show a newer release later.
2019 2018-10-01 – 2019-09-30	USD 24.38 million Exact value Exact value: 24382000 USD 2018-10-01 – 2019-09-30: 24382000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2019-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 24382000 USD Concept: fundies:NetIncome Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:NetIncome: 24382000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312521337663/d228317d10k.htm#1150233 Filing: 000119312521337663 The citation records this snapshot. The page link may show a newer release later.	USD 36.18 million Exact value Exact value: 36175000 USD 2018-10-01 – 2019-09-30: 36175000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2019-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 36175000 USD Concept: fundies:OperatingCashFlow Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 36175000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312521337663/d228317d10k.htm#957020 Filing: 000119312521337663 The citation records this snapshot. The page link may show a newer release later.	USD 3.8 million Exact value Exact value: 3797000 USD 2018-10-01 – 2019-09-30: 3797000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2019-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 3797000 USD Concept: fundies:CapitalExpenditure Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2019-09-30&surface=latest&period_type=duration&start=2018-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3797000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312521337663/d228317d10k.htm#2000676 Filing: 000119312521337663 The citation records this snapshot. The page link may show a newer release later.	USD 32.38 million Calculation and evidence 36175000 − 3797000 USD Exact free cash flow: 32378000 USD 2018-10-01 – 2019-09-30: 36175000 USD · Inspect Operating Cash Flow · Source 2018-10-01 – 2019-09-30: 3797000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2019-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 32378000 USD Concept: free-cash-flow Period: 2018-10-01 to 2019-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 36175000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312521337663/d228317d10k.htm#957020 Filing: 000119312521337663 Input fundies:CapitalExpenditure: 3797000 USD (2018-10-01 to 2019-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312521337663/d228317d10k.htm#2000676 Filing: 000119312521337663 The citation records this snapshot. The page link may show a newer release later.
2020 2019-10-01 – 2020-09-30	USD 46.19 million Exact value Exact value: 46186000 USD 2019-10-01 – 2020-09-30: 46186000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2020-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 46186000 USD Concept: fundies:NetIncome Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:NetIncome: 46186000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1034338 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 47.98 million Exact value Exact value: 47976000 USD 2019-10-01 – 2020-09-30: 47976000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2020-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 47976000 USD Concept: fundies:OperatingCashFlow Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 47976000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#835230 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 3.3 million Exact value Exact value: 3299000 USD 2019-10-01 – 2020-09-30: 3299000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2020-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 3299000 USD Concept: fundies:CapitalExpenditure Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2020-09-30&surface=latest&period_type=duration&start=2019-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3299000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1850361 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 44.68 million Calculation and evidence 47976000 − 3299000 USD Exact free cash flow: 44677000 USD 2019-10-01 – 2020-09-30: 47976000 USD · Inspect Operating Cash Flow · Source 2019-10-01 – 2020-09-30: 3299000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2020-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 44677000 USD Concept: free-cash-flow Period: 2019-10-01 to 2020-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 47976000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#835230 Filing: 000119312522290521 Input fundies:CapitalExpenditure: 3299000 USD (2019-10-01 to 2020-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1850361 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.
2021 2020-10-01 – 2021-09-30	USD 71.41 million Exact value Exact value: 71407000 USD 2020-10-01 – 2021-09-30: 71407000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2021-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 71407000 USD Concept: fundies:NetIncome Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:NetIncome: 71407000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1062919 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 66.87 million Exact value Exact value: 66865000 USD 2020-10-01 – 2021-09-30: 66865000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2021-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 66865000 USD Concept: fundies:OperatingCashFlow Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 66865000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#834678 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 18.31 million Exact value Exact value: 18312000 USD 2020-10-01 – 2021-09-30: 18312000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2021-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 18312000 USD Concept: fundies:CapitalExpenditure Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2021-09-30&surface=latest&period_type=duration&start=2020-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18312000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1821692 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 48.55 million Calculation and evidence 66865000 − 18312000 USD Exact free cash flow: 48553000 USD 2020-10-01 – 2021-09-30: 66865000 USD · Inspect Operating Cash Flow · Source 2020-10-01 – 2021-09-30: 18312000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2021-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 48553000 USD Concept: free-cash-flow Period: 2020-10-01 to 2021-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 66865000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#834678 Filing: 000119312522290521 Input fundies:CapitalExpenditure: 18312000 USD (2020-10-01 to 2021-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1821692 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.
2022 2021-10-01 – 2022-09-30	USD 42.46 million Exact value Exact value: 42459000 USD 2021-10-01 – 2022-09-30: 42459000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Net Income: 42459000 USD Concept: fundies:NetIncome Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ANetIncome&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:NetIncome: 42459000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1092310 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 82.36 million Exact value Exact value: 82361000 USD 2021-10-01 – 2022-09-30: 82361000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Operating Cash Flow: 82361000 USD Concept: fundies:OperatingCashFlow Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3AOperatingCashFlow&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 82361000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#834172 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 8.62 million Exact value Exact value: 8615000 USD 2021-10-01 – 2022-09-30: 8615000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Capital Expenditure: 8615000 USD Concept: fundies:CapitalExpenditure Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172/explain?concept=fundies%3ACapitalExpenditure&period=2022-09-30&surface=latest&period_type=duration&start=2021-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8615000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1791117 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.	USD 73.75 million Calculation and evidence 82361000 − 8615000 USD Exact free cash flow: 73746000 USD 2021-10-01 – 2022-09-30: 82361000 USD · Inspect Operating Cash Flow · Source 2021-10-01 – 2022-09-30: 8615000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MERIDIAN BIOSCIENCE INC · 2022-09-30 MERIDIAN BIOSCIENCE INC (edgar:794172) Free cash flow: 73746000 USD Concept: free-cash-flow Period: 2021-10-01 to 2022-09-30 Values: Latest reported Published: 2026-11-02T15:40:56Z Snapshot: ba2bc71d3143c8edb8d74c2c9b6cd2abf02b2ef3670761bfee653929655bbfb4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/794172?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 82361000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#834172 Filing: 000119312522290521 Input fundies:CapitalExpenditure: 8615000 USD (2021-10-01 to 2022-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/794172/000119312522290521/d384542d10k.htm#1791117 Filing: 000119312522290521 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

125 filings · 10,188 latest values · 10,188 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000794172, 794172, VIVO, edgar:794172

Also known as MERIDIAN BIOSCIENCE INC, MERIDIAN BIOSCIENCE, INC., MERIDIAN DIAGNOSTICS INC, Meridian Bioscience, Inc.

MERIDIAN BIOSCIENCE INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2021-10-01 – 2022-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation